Feasibility Study of Metronomic Chemotherapy for Locally Advanced Her2- Positive Breast Cancer (TraQ-Me 01)

NCT01329640 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced HER2-positive Breast Cancer

Interventions

DEVICE: Drug: Paclitaxel; trastuzumab; doxorrubicin; cyclophosphamide

Sponsor

Instituto do Cancer do Estado de São Paulo

Collaborators

[object Object]